{"id":495487,"date":"2024-01-25T14:04:53","date_gmt":"2024-01-25T19:04:53","guid":{"rendered":"https:\/\/platohealth.ai\/beyond-animal-testing-organ-on-a-chip-companies-usher-in-a-new-era-for-drug-trials\/"},"modified":"2024-01-25T14:05:21","modified_gmt":"2024-01-25T19:05:21","slug":"beyond-animal-testing-organ-on-a-chip-companies-usher-in-a-new-era-for-drug-trials","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/beyond-animal-testing-organ-on-a-chip-companies-usher-in-a-new-era-for-drug-trials\/","title":{"rendered":"Beyond Animal Testing: Organ-on-a-Chip Companies Usher in a New Era for Drug Trials","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
Nearly two decades ago, a groundbreaking discovery in the field of biomedical research emerged, known as organ-on-a-chip technology, which quickly captivated the interest of scientists across the globe. Led by a bioengineer Donald E. Ingber<\/a> at Harvard University, this innovative approach aimed to recreate the complex structure and functions of human organs within laboratory settings. By using specialized techniques, researchers successfully developed miniature models of organs, opening up new possibilities for studying human physiology in the lab.<\/p>\n